The difficulties faced by the generic and biosimilar pharmaceutical industry and the economic unsustainability of many of its medicines are reflected in the high number of…
In Conversation
India has an advantage in terms of demographics, digitalisation, and democracy – which encourages and enables creativity and innovation
The Indian pharma industry is very patient-centric, and all its changes ultimately strive to reduce prices, making medicines more affordable and accessible
Despite our size, Servier Portugal has a significant impact and contribution to the company's global value
While we highly prioritize adherence to regulations, we are actively developing a fast-track approach for essential medicines to address critical healthcare needs swiftly
The focus on top-tier research in Portugal has the potential to drive technology transfer from the academic lab to commercial success
We want to be major contributors to the evolution of the healthcare ecosystem as Morocco moves towards universal healthcare
Starting from scratch in foreign markets requires dedication and adaptability, but it also presents opportunities for growth and learning.
We need a balanced approach that would allow for reasonable medication prices while ensuring the long-term sustainability of the social security system
I am confident that over time, with joint work between innovators and health authorities, we will find a solution that will get the necessary treatments to…
By establishing our on-ground presence in the dynamic and commercial hub of Casablanca, we can contribute to the steady growth of the healthcare landscape in Morocco…
ANAM has played, and will continue to play, a central role in supporting the reform processes
